Owing to a myriad factors such as inadequate physical activities, unhealthy food habits as well as surge in alcohol consumption, blood cancer continues to endanger public health with growing prevalence round the globe. Besides genetic factors, the aforementioned factors remain major contributing factors for the growing burden of blood cancer. Several active government initiatives pertaining adequate reimbursement and increased spending towards healthcare are likely to underpin growth in blood cancer diagnostics market in the coming years. Stakeholders in blood cancer diagnostics market are integrating resources to offer advanced diagnostics tactics that leverage early diagnosis. Painful bone marrow biopsy continues to baffle patients who therefore demonstrate reasonable aversion in taking such tests. To offset this hurdle, global players are keen on developing novel diagnostic procedures that encourage greater adoption. Liquid Biopsy is widely accepted means to confirm blood ca...